To hear about similar clinical trials, please enter your email below
Trial Title:
Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
NCT ID:
NCT06346080
Condition:
Esophageal Cancer
Gastric Cancer
Conditions: Official terms:
Stomach Neoplasms
Esophageal Neoplasms
Conditions: Keywords:
Esophageal cancer
Survey
Gastric cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Intervention model description:
A survey will be conducted in a single group of participants from different geographical
regions and backgrounds
Primary purpose:
Other
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Survey
Description:
Discrete choice survey
Arm group label:
Survey participants
Summary:
The goal of this survey is to investigate the participants' preference for a specific
screening/diagnostic tool to detect and assess gastro-esophageal cancer.
The main question it aims to answer are:
- Which diagnostic modality is preferred by patients and the general population?
- Which features of the diagnostic test are most detrimental in the decision-making
for one or the other modality?
- Are geographical differences present in regard to the preference for a diagnostic
modality?
Participants will be asked to complete a survey of 20-25min, including a brief intake
regarding their socio-economic status. This approach will allow us to correct for
confounding factors.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Individuals >18yo to 75yo (upper age limit of Barrett's surveillance)
2. Access to computer or smartphone
3. Clear understanding of available languages of the experiment (English, French,
Dutch, Spanish, German, Chinese, Japanese)
Exclusion Criteria:
1. Individuals less than 18yo and more than 75yo
2. Incarcerated individuals
Gender:
All
Minimum age:
18 Years
Maximum age:
85 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
University Hospitals Leuven
Address:
City:
Leuven
Zip:
3000
Country:
Belgium
Status:
Recruiting
Contact:
Last name:
Stijn Vanstraelen, MD
Phone:
16347863
Phone ext:
0032
Email:
stijn.vanstraelen@kuleuven.be
Start date:
August 1, 2024
Completion date:
August 1, 2026
Lead sponsor:
Agency:
KU Leuven
Agency class:
Other
Source:
KU Leuven
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06346080
